157 related articles for article (PubMed ID: 33036421)
21. Overexpression of high mobility group box 1 (HMGB1) has no correlation with the prognosis in glioma.
Jia L; Song Y; Song H; Wang G; Fan W; Li X; Zheng H; Yao A
Biomark Med; 2019 Jul; 13(10):851-863. PubMed ID: 31241346
[No Abstract] [Full Text] [Related]
22. IGFBP2 expression predicts IDH-mutant glioma patient survival.
Huang LE; Cohen AL; Colman H; Jensen RL; Fults DW; Couldwell WT
Oncotarget; 2017 Jan; 8(1):191-202. PubMed ID: 27852048
[TBL] [Abstract][Full Text] [Related]
23. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
24. Loss of semaphorin-neuropilin-1 signaling causes dysmorphic vascularization reminiscent of alveolar capillary dysplasia.
Joza S; Wang J; Fox E; Hillman V; Ackerley C; Post M
Am J Pathol; 2012 Dec; 181(6):2003-17. PubMed ID: 23063659
[TBL] [Abstract][Full Text] [Related]
25. Gene expression microarray analysis reveals prognostic markers of survival in high grade astrocytomas.
Yang J; Hou Z; Wang C; Wang H; Zhang H
Neurol Res; 2018 Sep; 40(9):744-751. PubMed ID: 29781781
[TBL] [Abstract][Full Text] [Related]
26. Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma.
Xu BJ; An QA; Srinivasa Gowda S; Yan W; Pierce LA; Abel TW; Rush SZ; Cooper MK; Ye F; Shyr Y; Weaver KD; Thompson RC
Int J Oncol; 2012 Jun; 40(6):1995-2003. PubMed ID: 22307528
[TBL] [Abstract][Full Text] [Related]
27. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneous nuclear ribonucleoproteins and their interactors are a major class of deregulated proteins in anaplastic astrocytoma: a grade III malignant glioma.
Polisetty RV; Gautam P; Gupta MK; Sharma R; Uppin MS; Challa S; Ankathi P; Purohit AK; Renu D; Harsha HC; Pandey A; Sirdeshmukh R
J Proteome Res; 2013 Jul; 12(7):3128-38. PubMed ID: 23741984
[TBL] [Abstract][Full Text] [Related]
29. Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux.
Wen ZP; Zeng WJ; Chen YH; Li H; Wang JY; Cheng Q; Yu J; Zhou HH; Liu ZZ; Xiao J; Chen XP
J Exp Clin Cancer Res; 2019 Jul; 38(1):298. PubMed ID: 31291988
[TBL] [Abstract][Full Text] [Related]
30. M2-like tumor-associated macrophages drive vasculogenic mimicry through amplification of IL-6 expression in glioma cells.
Zhang L; Xu Y; Sun J; Chen W; Zhao L; Ma C; Wang Q; Sun J; Huang B; Zhang Y; Li X; Qu X
Oncotarget; 2017 Jan; 8(1):819-832. PubMed ID: 27903982
[TBL] [Abstract][Full Text] [Related]
31. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
32. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.
Weng W; Chen X; Gong S; Guo L; Zhang X
Neurol Res; 2018 Nov; 40(11):917-922. PubMed ID: 30074469
[TBL] [Abstract][Full Text] [Related]
33. High level of Sema3C is associated with glioma malignancy.
Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of mitochondrial pyruvate carrier in isocitrate dehydrogenase-mutant glioma.
Karsy M; Guan J; Huang LE
J Neurosurg; 2018 Mar; 130(1):56-66. PubMed ID: 29547090
[TBL] [Abstract][Full Text] [Related]
35. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.
Alafate W; Zuo J; Deng Z; Guo X; Wu W; Zhang W; Xie W; Wang M; Wang J
Pathol Res Pract; 2019 Oct; 215(10):152557. PubMed ID: 31353228
[TBL] [Abstract][Full Text] [Related]
36. Plate-Based Assay for Measuring Direct Semaphorin-Neuropilin Interactions.
Parker MW; Vander Kooi CW
Methods Mol Biol; 2017; 1493():73-87. PubMed ID: 27787843
[TBL] [Abstract][Full Text] [Related]
37. KDR and Sema3 genes expression in bone marrow stromal cells and hematopoietic cells from leukemia patients and normal individuals.
Wang Z; Li Y; Wu X; Cheng S; Yang L; Wu Y
Hematology; 2005 Aug; 10(4):307-12. PubMed ID: 16085543
[TBL] [Abstract][Full Text] [Related]
38. Integrative analyses identify a DNA damage repair gene signature for prognosis prediction in lower grade gliomas.
Pang FM; Yan H; Mo JL; Li D; Chen Y; Zhang L; Liu ZQ; Zhou HH; Wu J; Li X
Future Oncol; 2020 Mar; 16(8):367-382. PubMed ID: 32065545
[No Abstract] [Full Text] [Related]
39. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
40. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]